EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are all adaptogens created equal? A comparative review and trend analysis of clinical data

Guido Masé, Aaron Jenks, Marisa Williams, Thomas Brendler

Frontiers in Pharmacology · 09.11.2026 · 17

DOI: 10.3389/fphar.2026.1980715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 09.11.2026. Verfasst von Guido Masé und 3 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The use of adaptogenic ingredients in dietary supplements and herbal medicines is increasingly common. The pharmacological effects of generally acknowledged adaptogens at tissue and cellular levels through various mechanisms result in a range of clinically relevant effects, such as increasing resilience during the stress response, supporting more rapid recovery from stressors, and decreasing the intensity of post-stress exhaustion. While clinical effects for adaptogens should be non-specific, traditional use and commercial marketing suggest different applications for individual adaptogens. To this end, the authors conducted a comparative review of clinical research to test the hypothesis based on traditional understanding that adaptogen-specific effect profiles exist and that adaptogens have differentiable clinical relevance.

Methods

A comparative trend analysis of clinical evidence using accepted vote-counting methodology and data synthesis was conducted on seven generally acknowledged adaptogens: ashwagandha ( Withania somnifera ), schisandra ( Schisandra spp.), eleuthero ( Eleutherococcus senticosus ), rhodiola ( Rhodiola rosea ), Asian ginseng ( Panax ginseng ), reishi (species of Ganoderma ), and cordyceps (species of Cordyceps and Ophiocordyceps along with affiliated Paecilomyces hepiali ).

Results

A total of 275 clinical studies were included and scored based on primary and secondary outcomes across seven clinical outcome domains: energy, cognition, mood, sleep, immunologic and inflammatory balance, cardiometabolic health, and the reproductive system. Trend analysis of this dataset identified which adaptogens showed significant positive directions of effect in each domain, and demonstrated some significant differences in clinical outcome distribution profiles for each adaptogen.

Discussion

Individual adaptogens show unique effect profiles measured by the outcomes of clinical research in diverse domains, corroborated by traditional use.

Zitieren

APA

Masé, G., Jenks, A., Williams, M., & Brendler, T. (2026). Are all adaptogens created equal? A comparative review and trend analysis of clinical data. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1980715

Vancouver

Masé G, Jenks A, Williams M, Brendler T. Are all adaptogens created equal? A comparative review and trend analysis of clinical data. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1980715

BibTeX
@article{Mas2026,
  author = {Masé, Guido and Jenks, Aaron and Williams, Marisa and Brendler, Thomas},
  title = {Are all adaptogens created equal? A comparative review and trend analysis of clinical data},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1980715}
}
Kostenlos starten →